Noradrenaline Kabi (Noradrenaline Tartrate)

Noradrenaline, the active ingredient in Noradrenaline Kabi, is a sympathomimetic presented as a solution for injection for intravenous use. It is used to raise blood pressure in patients with hypotension, septic shock, or cardiac arrest.

GNH USA supplies Noradrenaline Kabi as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenaline Kabi is a sympathomimetic agent used in cardiovascular emergencies.

- Hypotension: restores systemic vascular resistance and improves arterial pressure in acute low‑pressure states. - Septic shock: counteracts vasodilatory failure to maintain perfusion pressure during severe infection. - Cardiac arrest: supports coronary and cerebral perfusion during resuscitation efforts.

Noradrenaline Kabi may cause a range of adverse reactions, varying from frequent to rare.

Common Side Effects: - Headache: mild to moderate headache during infusion. - Tachycardia: increased heart rate, especially at higher infusion rates. - Arrhythmia: irregular heart rhythm such as premature beats. - Peripheral ischemia: reduced blood flow to extremities causing coldness or pain.

Serious or Rare Side Effects: - Severe hypertension: abrupt rise in blood pressure that may lead to stroke. - Myocardial ischemia: reduced coronary blood flow causing chest pain or infarction. - Extravasation injury: tissue necrosis if the solution leaks into surrounding tissue.

When using Noradrenaline Kabi, careful monitoring and specific precautions are required.

- Dose titration: adjust infusion rate based on continuous blood pressure monitoring. - Cardiac monitoring: observe for arrhythmias and ischemic changes during therapy. - Fluid status: ensure adequate intravascular volume before initiating infusion. - Contraindications: avoid use in patients with uncorrected pheochromocytoma or severe peripheral vascular disease. - Drug compatibility: administer through a dedicated line; avoid mixing with solutions that may precipitate. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline Kabi can interact with several drug classes; awareness of major and moderate interactions helps prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis when combined with norepinephrine. - Tricyclic antidepressants: additive sympathomimetic effect may cause severe hypertension. - Beta‑blockers: may blunt beta‑1 mediated increase in cardiac output.

Moderate Interactions (Monitor Closely): - Vasopressin: combined vasoconstriction may lead to excessive vascular tone. - Calcium channel blockers: may affect vascular response to norepinephrine. - Inhaled anesthetics (e.g., halothane): can potentiate arrhythmogenic potential.